2 de febrero de 2017 / 13:24 / hace 7 meses

BRIEF-FDA grants Abbott first commercial authorization for molecular test to detect zika virus using whole blood

Feb 2 (Reuters) - Abbott Laboratories -

* U.S. FDA grants Abbott the first commercial authorization for a molecular test to detect zika virus using whole blood

* FDA authorized its molecular test, abbott realtime zika test, to detect zika virus in whole blood for emergency use Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below